A Review of Oral Semaglutide Available Evidence: A New Era of Management of Diabetes with Peptide in a Pill Form
Source : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302409/
Glucagon-like peptide 1 receptor agonists (GLP-1RAs) have gained an important place in the management of diabetes management because of their exceptional glucose-lowering, weight lowering and cardiovascular (CV) benefits. Despite recommendations by various clinical practice guidelines and benefits, their usage in clinical practice was limited because of being injectable in nature.
Relevance: The current review discusses the various aspects of oral semaglutide and its place in clinical practice.